favipiravir

Clinical trials conducted in China have returned promising results for a treatment for patients infected with COVID-19, using an existing antiviral compound that has been used against similar viruses. Typically used to treat new strains of influenza, favipiravir is an antiviral drug produced by Fujifilm Toyama Chemical that has beenread more